Literature DB >> 22832139

Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.

Amar Mukund1, S Rajesh, Ankur Arora, Yashwant Patidar, Deepak Jain, Shiv K Sarin.   

Abstract

PURPOSE: Balloon-occluded retrograde transvenous obliteration (BRTO) is a widely accepted treatment for gastric varices, but data are limited in regard to its role in the management of hepatic encephalopathy (HE). This study evaluated the efficacy of BRTO with foam sclerotherapy in the management of HE arising as a result of spontaneous large portosystemic shunts.
MATERIALS AND METHODS: Eight sessions of BRTO with sodium tetradecyl sulfate foam were performed in seven patients with cirrhosis complicated by HE. All patients had portosystemic communication (ie, gastro-/lienorenal shunt) on preprocedure computed tomography. Clinical and laboratory parameters including arterial ammonia level were evaluated in all patients before and after the procedure.
RESULTS: Technical success rates were 86% (six of seven) for the first BRTO session and 100% (one of one) for the second. Follow-up imaging revealed complete obliteration of the varices in five of seven patients (71%) and partial obliteration in the remaining two. Immediate clinical improvement of HE was observed in six of seven patients (86%), with postprocedural decrease in arterial ammonia levels; one patient showed delayed improvement. Procedure-related complications (eg, abnormal liver function test results, acute kidney injury with leukocytosis) were encountered in two patients. All patients showed clinical and symptomatic improvement at the time of discharge and during a follow-up of 4 months (with visits at 1 mo and 3 mo later).
CONCLUSIONS: Initial experience suggests that BRTO is an effective procedure in the management of HE arising as a result of large portosystemic shunts.
Copyright © 2012 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22832139     DOI: 10.1016/j.jvir.2012.05.046

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  18 in total

1.  Balloon-Occluded Retrograde Transvenous Obliteration (BRTO): A Novel Method of Control of Bleeding from Post-Glue Ulcer over Gastric Varices. Report of Two Cases and Review of Literature.

Authors:  Ritesh Prajapati; Piyush Ranjan; Arun Gupta; Ajit K Yadav
Journal:  J Clin Exp Hepatol       Date:  2016-08-31

2.  Response to Yang et al.

Authors:  Edward Wolfgang Lee; Stephen T Kee
Journal:  Am J Gastroenterol       Date:  2018-10-25       Impact factor: 10.864

Review 3.  Evolution of Retrograde Transvenous Obliteration Techniques.

Authors:  Mihir Patel; Christopher Molvar
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

Review 4.  Portosystemic shunt syndrome and endovascular management of hepatic encephalopathy.

Authors:  Wael E Saad
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

5.  Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy-A single-center experience in 21 patients from Kerala.

Authors:  Cyriac Abby Philips; Lijesh Kumar; Philip Augustine
Journal:  Indian J Gastroenterol       Date:  2017-11-10

Review 6.  Balloon-occluded retrograde transvenous obliteration of varices: focusing on the portal hemodynamics and the recent techniques.

Authors:  Shozo Hirota; Kaoru Kobayashi; Yasukazu Kako; Haruyuki Takaki; Koichiro Yamakado
Journal:  Hepatol Int       Date:  2017-09-05       Impact factor: 6.047

7.  Effective balloon-occluded retrograde transvenous obliteration of the superior mesenteric vein-inferior vena cava shunt in a patient with hepatic encephalopathy after living donor liver transplantation.

Authors:  Zhassulan Baimakhanov; Akihiko Soyama; Mitsuhisa Takatsuki; Yusuke Inoue; Hajime Matsushima; Masaaki Hidaka; Amane Kitasato; Tomohiko Adachi; Tamotsu Kuroki; Ichiro Sakomoto; Susumu Eguchi
Journal:  Clin J Gastroenterol       Date:  2014-05-15

8.  Percutaneous transvenous shunt occlusion for portosystemic encephalopathy due to lenvatinib administration to a patient with hepatocellular carcinoma and portosystemic shunt.

Authors:  Maiko Namba; Tomokazu Kawaoka; Hiroshi Aikata; Kenichiro Kodama; Shinsuke Uchikawa; Kazuki Ohya; Kei Morio; Hatsue Fujino; Takashi Nakahara; Eisuke Murakami; Masami Yamauchi; Masataka Tsuge; Akira Hiramatsu; Michio Imamura; Yasutaka Baba; Kazuo Awai; Kazuaki Chayama
Journal:  Clin J Gastroenterol       Date:  2019-01-31

9.  Combined Balloon-, Plug- and Coil-assisted Retrograde Transvenous Obliteration of Multiple Portosystemic Shunts to Treat Recurrent Hepatic Encephalopathy: A Case Report.

Authors:  Karan M Anandpara; Amar Mukund; Shiv K Sarin
Journal:  J Clin Exp Hepatol       Date:  2019-12-26

10.  Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy.

Authors:  Narendra S Choudhary; Sanjay Saran Baijal; Sanjiv Saigal; Amit Agarwal; Neeraj Saraf; Rohit Khandelwal; Vaibhav Jain; Anubhav Harish Khandelwal; Abhay Kapoor; Deepak Jain; Smurti R Misra; Rajesh Puri; Randhir Sud; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2017-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.